Pacer Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.15M Buy
18,230
+5,723
+46% +$661K 0.01% 969
2026
Q1
$1.5M Sell
12,507
-6,921
-36% -$908K ﹤0.01% 1060
2025
Q4
$2.65M Sell
19,428
-303
-2% -$43.6K 0.01% 948
2025
Q3
$2.91M Buy
19,731
+195
+1% +$27K 0.01% 904
2025
Q2
$2.53M Buy
19,536
+1,047
+6% +$127K 0.01% 929
2025
Q1
$2.21M Sell
18,489
-7,898
-30% -$979K 0.01% 917
2024
Q4
$3.06M Buy
26,387
+8,366
+46% +$1.06M 0.01% 814
2024
Q3
$2.43M Sell
18,021
-14,181
-44% -$1.9M 0.01% 889
2024
Q2
$4.37M Buy
32,202
+14,480
+82% +$1.97M 0.01% 623
2024
Q1
$2.29M Buy
17,722
+266
+2% +$32.1K 0.01% 798
2023
Q4
$2M Buy
17,456
+1,451
+9% +$145K 0.01% 775
2023
Q3
$1.46M Buy
16,005
+358
+2% +$36.9K 0.01% 690
2023
Q2
$1.76M Buy
15,647
+1,355
+9% +$143K 0.01% 780
2023
Q1
$1.5M Buy
14,292
+11,638
+439% +$1.22M 0.01% 778
2022
Q4
$293K Buy
2,654
+2,001
+306% +$210K ﹤0.01% 1794
2022
Q3
$57K Sell
653
-8
-1% -$727 ﹤0.01% 1907
2022
Q2
$52K Sell
661
-12,515
-95% -$1.03M ﹤0.01% 2106
2022
Q1
$1.12M Buy
13,176
+691
+6% +$66.2K 0.01% 862
2021
Q4
$1.5M Buy
12,485
+1,863
+18% +$231K 0.02% 968
2021
Q3
$1.31M Buy
10,622
+72
+0.7% +$9.27K 0.02% 782
2021
Q2
$1.27M Sell
10,550
-3,021
-22% -$345K 0.02% 760
2021
Q1
$1.43M Sell
13,571
-130
-0.9% -$13.2K 0.02% 628
2020
Q4
$1.4M Buy
13,701
+870
+7% +$81.8K 0.03% 555
2020
Q3
$1.08M Sell
12,831
-2,719
-17% -$212K 0.02% 668
2020
Q2
$1.01M Buy
15,550
+11,981
+336% +$791K 0.02% 555
2020
Q1
$248K Buy
3,569
+294
+9% +$23.2K 0.01% 355
2019
Q4
$258K Sell
3,275
-15,707
-83% -$1.22M 0.01% 1039
2019
Q3
$1.51M Buy
18,982
+1,855
+11% +$146K 0.03% 640
2019
Q2
$1.43M Buy
17,127
+61
+0.4% +$4.86K 0.04% 655
2019
Q1
$1.35M Buy
17,066
+16,611
+3,651% +$1.21M 0.04% 378
2018
Q4
$30K Sell
455
-9,221
-95% -$638K ﹤0.01% 327
2018
Q3
$773K Buy
9,676
+1,464
+18% +$109K 0.03% 750
2018
Q2
$553K Buy
8,212
+1,364
+20% +$99K 0.03% 880
2018
Q1
$527K Buy
6,848
+1,089
+19% +$80.5K 0.03% 728
2017
Q4
$393K Buy
5,759
+1,935
+51% +$128K 0.03% 781
2017
Q3
$239K Buy
3,824
+351
+10% +$21K 0.02% 954
2017
Q2
$193K Sell
3,473
-228
-6% -$11.9K 0.02% 1016
2017
Q1
$186K Buy
3,701
+121
+3% +$5.9K 0.02% 947
2016
Q4
$177K Buy
3,580
+251
+8% +$12.7K 0.03% 908
2016
Q3
$175K Sell
3,329
-15,054
-82% -$738K 0.03% 873
2016
Q2
$820K Buy
18,383
+15,571
+554% +$677K 0.13% 146
2016
Q1
$115K Buy
2,812
+219
+8% +$8.06K 0.03% 568
2015
Q4
$95K Buy
+2,593
New +$93.8K 0.02% 615

Other funds holding XYL

Pacer Advisors's XYL Position: Q2 2026 in Review

Pacer Advisors increased its Xylem (XYL) stake by 46% in Q2 2026, buying an estimated $661K and bringing the position to 18,230 shares worth $2.15M. The position accounts for 0.01% of the portfolio, ranked #969.

Pacer Advisors first reported a position in XYL in Q4 2015 and has held it in 43 quarters since. The position peaked at $4.37M in Q2 2024. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Pacer Advisors held 18,230 shares of Xylem worth $2.15M as of Q2 2026.
  • Pacer Advisors bought 5,723 Xylem shares in Q2 2026, an estimated $661K.
  • Xylem made up 0.01% of Pacer Advisors's portfolio in Q2 2026, its #969 holding.
  • Pacer Advisors first reported a position in Xylem in Q4 2015 and has held it in 43 quarters since.
  • Pacer Advisors's Xylem position peaked at $4.37M in Q2 2024.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.